Clinical journal of oncology nursing最新文献

Dyspnea is prevalent among patients with cancer at end of life. The intensity of this symptom increases as patients near death. Pharmacologic and nonpharmacologic interventions are currently used to lessen dyspnea at end of l.

A large academic medical center in the southwestern United States established a cancer network of cobranded partnerships with domestic healthcare systems to extend the reach of the institution's mission to end cancer and im.

Background: Radiation-induced diarrhea (RID) is a distressing side effect of radiation to the abdominal and pelvic areas and warrants evidence-based interventions.

Objectives: This article reviews evidence for updates to the Oncology Nursing Society (ONS) symptom intervention recommendations for treating and preventing RID.

Methods: The ONS RID project team reviewed primary interventional studies, systematic reviews, and clinical practice guidelines. Results were categorized based on quality and level of evidence, outcome magnitude, and agreement between studies.

Findings: The team categorized the effectiveness of nutritional supplementation as not established, sulfasalazine as unlikely to be effective, SpaceOAR™ as effective with caution for patients with prostate cancer, and probiotics as recommended for practice. The studies reviewed consistently reported favorable effects of probiotics use during and after radiation with minimal to no adverse events.

Background: Newly diagnosed patients with lung cancer experience significant challenges navigating a fragmented health system. Nurse navigators can use clinical expertise and coordination to address barriers to care.

Objectives: This quality improvement project aimed to expedite the selection and initiation of first-line treatment for patients with stage III or IV lung cancer. Using a nurse navigator process early on in care, coupled with liquid biopsy, this project focused on reducing the time from tissue biopsy to treatment decision.

Methods: The team performed a retrospective chart review 12 months preimplementation and 8 months postimplementation.

Findings: Using liquid biopsy, the time to treatment initiation was 21 days compared to 36 days with tissue biopsy only (p = 0.003). Postimplementation, median days to treatment decreased from 34 to 23.5 (p = 0.027), and treatment decisions made during the initial medical oncology visit increased from 38% to 55%.

I have been a nurse for more than 25 years, but I consider myself relatively new to oncology. For the past three years, I have supported patients with head and neck cancer in Dallas, Texas. I know all cancer care nurses belie.

In September 2021, California Governor Gavin Newsom signed Senate Bill 311 (Ryan's Law), mandating that healthcare facilities permit terminally ill patients to use their own medical cannabis under the Compassionate Access t.

Background: Virtual reality (VR) is a useful therapeutic tool in various patient populations. Patients with cancer may benefit from VR during chemotherapy to address concerns like negative affect, stress, and physical side effects.

Objectives: The aim of this study was to evaluate the effects of VR on pain, stress, and affect in patients with cancer receiving chemotherapy.

Methods: Ninety patients were randomized into control and study groups. The study group received a 12-minute VR session while undergoing chemotherapy. Participants took surveys measuring stress, pain, affect, cybersickness, and satisfaction, and heart rates were measured before and halfway through.

Findings: There were statistically significant decreases in stress and pain among patients using VR. Positive affect was significantly elevated, and negative affect was significantly reduced. Heart rate measurements indicated reduced stress. Most patients reported high satisfaction with VR and experienced no feelings of cybersickness.

The Oncology Nursing Society (ONS) celebrates 50 years of propelling oncology nursing work and care forward this year. During this golden anniversary year, we will reflect on what the oncology nursing profession has surpassed.

More than 30 states have passed anti-diversity, equity, and inclusion (DEI) legislation prohibiting or restricting DEI initiatives in public colleges and universities. This article examines anti-DEI legislation and its pote.

Background: The out-of-pocket cost of oral oncolytics led to the creation of patient assistance programs (PAPs) as an intervention to mitigate financial toxicity. Despite these programs, eligibility and accessibility barriers may disqualify patients from receiving financial assistance for prescribed oral oncolytics.

Objectives: The objective of this integrative review was to identify eligibility and accessibility barriers related to PAPs.

Methods: A comprehensive search was conducted in PubMed® and Ovid® databases for articles published from January 2014 through December 2023. Five articles were included in the review.

Findings: Eligibility and accessibility barriers of PAPs include insurance status, income ceilings, out-of-pocket costs, and prescription-to-initiation timeline delays. Overall, findings were mixed on what would qualify a patient for a PAP. Transparency from PAPs and the use of pharmacy-based interventions for PAPs can help clinicians efficiently prescribe oral oncolytics.